top of page
Our pipeline
The impossible is simply what hasn’t been achieved yet. SwiftPharma’s R&D program is focused on what’s next in various areas, from healthcare to agriculture.
IMMUNOLOGY
Coronavirus/Influenza
combo vaccine
Preclinical
Highly Mannosylated VLP
Norovirus
Discovery
Highly Mannosylated VLP
Poliovirus
Discovery
Highly Mannosylated VLP
REGENERATIVE MEDICINE
Diabetic foot ulcer
Discovery
Sacran-crosslinked Spidroin/Collagen Type I hydrogel
Orthopeadic
Discovery
Sacran-crosslinked Spidroin/Collagen Type I hydrogel
AESTHETICS
Injectable dermal filler
Formulation
HA-crosslinked Spidroin/Collagen Type I
COSMETICS
Sacran-crosslinked Spidroin/Collagen Type I hydrogel
Marketing
Film Forming,
anti-aging
bottom of page